Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 15, 2024
DUBLIN, Feb. 8, 2024 /PRNewswire/ — Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p.m. GMT) on Thursday, Feb. 15, 2024 to discuss the company’s fourth quarter and year-end 2023 financial results. Management will also discuss financial expectations for 2024 and provide an update on the company.
Related news for (ALKS)
- Alkermes plc Announces Agreement to Acquire Avadel Pharmaceuticals plc
- Alkermes Presents Detailed Positive Results from Vibrance-1 Phase 2 Study of Alixorexton in Patients with Narcolepsy Type 1 at World Sleep Congress 2025
- Alkermes to Present Detailed Positive Results From Vibrance-1 Phase 2 Study Evaluating Alixorexton in Patients With Narcolepsy Type 1 at World Sleep 2025
- Alkermes plc Reports Second Quarter 2025 Financial Results
- Alkermes Announces Positive Topline Results From Vibrance-1 Phase 2 Study of Once-Daily Alixorexton in Patients With Narcolepsy Type 1